US FDA halts Sun Pharma’s trial on dermatological drugs; stock down
The federal agency has put on hold the trial of 12 mg of Deuruxolitinib clinical trial owing to a potential pulmonary embolism.
sun pharmas dermatological drugs
May 2023
